Get the Stockscreener App
3.08
4.64%
-0.15
After Hours:
3.12
0.04
+1.30%
Codexis Inc stock is traded at $3.08, with a volume of 702.48K.
It is down -4.64% in the last 24 hours and up +6.57% over the past month.
Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products, leveraging its proprietary CodeEvolver directed evolution technology platform. The firm's products and services include Biocatalysts and Enzymes. The company generates majority of its revenue through product sales and also licenses its technology platform CodeEvolver to pharmaceutical companies enabling them to use this technology, in-house, to engineer enzymes for their own businesses. Geographically, it derives revenue from the United States, Ireland, Switzerland, China and other markets.
See More
Previous Close:
$3.23
Open:
$3.19
24h Volume:
702.48K
Relative Volume:
1.24
Market Cap:
$219.87M
Revenue:
$70.14M
Net Income/Loss:
$-76.24M
P/E Ratio:
-3.6235
EPS:
-0.85
Net Cash Flow:
$-57.06M
1W Performance:
+5.48%
1M Performance:
+6.57%
6M Performance:
-11.75%
1Y Performance:
+62.96%
1-Day Range:
$3.06
$3.301
1-Week Range:
$2.83
$3.301
52-Week Range:
$1.51
$4.91
Codexis Inc Stock (CDXS) Company Profile
Name
Codexis Inc
Sector
Industry
Phone
650-421-8100
Address
200 PENOBSCOT DRIVE, REDWOOD CITY, CA
Codexis Inc Stock (CDXS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-09-23 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Mar-31-22 | Resumed | Piper Sandler | Overweight |
| Mar-02-22 | Resumed | Cowen | Outperform |
| Apr-12-21 | Initiated | Piper Sandler | Overweight |
| Mar-01-21 | Initiated | Stifel | Buy |
| Feb-26-21 | Reiterated | H.C. Wainwright | Buy |
| Mar-10-20 | Initiated | The Benchmark Company | Buy |
| Jan-17-19 | Upgrade | First Analysis Sec | Neutral → Outperform |
| May-16-18 | Initiated | Stephens | Overweight |
| Oct-13-17 | Reiterated | H.C. Wainwright | Buy |
| May-31-17 | Initiated | Jefferies | Buy |
| Jan-26-17 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| Jan-04-17 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Jan-06-16 | Initiated | H.C. Wainwright | Buy |
View All
Codexis Inc Stock (CDXS) Latest News
Nothing is Better Than Codexis Inc. (CDXS) stock at the moment - SETE News
Fred Alger Management LLC Sells 158,605 Shares of Codexis, Inc. (NASDAQ:CDXS) - MarketBeat
Wall Street SWOT: Codexis stock pivots to RNAi, analysts see enzyme potential - Investing.com
10% Owner Opaleye Management Inc. acquired 80,000 shares of Codexis Inc. [CDXS] - Knox Daily
Codexis Inc.: A Comprehensive Look at the Stock’s Ups and Downs - The InvestChronicle
Opaleye management increases stake in Codexis with $249k purchase By Investing.com - Investing.com Australia
Opaleye management increases stake in Codexis with $249k purchase - Investing.com
Casdin Capital, LLC Increases Stake in Codexis Inc - Yahoo Finance
Casdin Capital, LLC Increases Stake in Codexis Inc - GuruFocus.com
It makes sense and dollars to buy Codexis Inc. (CDXS) stock - SETE News
It would be worthwhile to take a closer look at Codexis Inc. (CDXS) - US Post News
Financial Snapshot: Analyzing Codexis Inc. (CDXS)’s Key Ratio Metrics - The Dwinnex
Codexis, Inc. (NASDAQ:CDXS) Major Shareholder Opaleye Management Inc. Purchases 45,000 Shares - Defense World
Opaleye Management Inc. buys Codexis shares worth over $3.3 million By Investing.com - Investing.com South Africa
Opaleye Management Inc. buys Codexis shares worth over $3.3 million By Investing.com - Investing.com Canada
Opaleye Management Inc. buys Codexis shares worth over $3.3 million - Investing.com
Opaleye Management Inc. buys Codexis shares worth over $3.3 million By Investing.com - Investing.com UK
Does Codexis Inc. (NASDAQ: CDXS) Still Need To Convince Analysts? - Stocks Register
Opaleye Management Inc. Buys 1,055,000 Shares of Codexis, Inc. (NASDAQ:CDXS) Stock - Defense World
Codexis, Inc. (NASDAQ:CDXS) Major Shareholder Opaleye Management Inc. Purchases 61,000 Shares of Stock - Defense World
Codexis (NASDAQ:CDXS) Stock Rating Reaffirmed by Cantor Fitzgerald - Defense World
Codexis (NASDAQ:CDXS) Rating Reiterated by Cantor Fitzgerald - MarketBeat
Opaleye Management Inc. Increases Stake in Codexis Inc. - GuruFocus.com
Opaleye Management Inc. Increases Stake in Codexis Inc. - Yahoo Finance
Opaleye Management Inc. Acquires 61,000 Shares of Codexis, Inc. (NASDAQ:CDXS) Stock - MarketBeat
Opaleye Management Inc. buys $193k worth of Codexis stock By Investing.com - Investing.com Canada
Opaleye Management Inc. buys $193k worth of Codexis stock - Investing.com
Codexis Inc. [CDXS] stock was sold by Dorgan Byron L at the price of US$42168.0 - Knox Daily
Jefferies downgrades CryoPort Inc (CYRX) stock to a Hold - Knox Daily
CrowdStrike (NASDAQ:CRWD) Stock Rating Reaffirmed by DA Davidson - MarketBeat
Citi maintains $300 shares target on CrowdStrike ahead of Fal.Con conference - Investing.com India
Major News for CrowdStrike Investors - MSN
CrowdStrike shares likely to be 'volatile' going into conference: Citi - MSN
CrowdStrike shares likely to be 'volatile' going into conference: Citi (NASDAQ:CRWD) - Seeking Alpha
Institutional investors have a lot riding on Codexis, Inc. (NASDAQ:CDXS) with 71% ownership - Simply Wall St
Codexis, Inc. (NASDAQ:CDXS) Short Interest Update - MarketBeat
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against CrowdStrike Holdings, Inc.CRWD - PR Newswire
Codexis Inc. (CDXS) Stock: A Year of Declines and Increases - The InvestChronicle
Canaccord sees colon blood test as attractive revenue stream for Exact - TipRanks
Johnson Investment Counsel Inc. Invests $239,000 in CrowdStrike Holdings, Inc. (NASDAQ:CRWD) - Defense World
Arizona State Retirement System Boosts Holdings in COPT Defense Properties (NYSE:CDP) - Defense World
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages CrowdStrike - GlobeNewswire
CrowdStrike Holdings And 4 Other Stocks Have High Sales Growth And An Above 3% Return on Equity - Via News Agency
CDXSCodexis, Inc. Latest Stock News & Market Updates - StockTitan
Pleasing Signs As A Number Of Insiders Buy Codexis Stock - Yahoo Finance
Codexis Announces New Employment Inducement Grants - GlobeNewswire
Codexis Announces New Employment Inducement Grants - StockTitan
Codexis Announces New Employment Inducement Grants - Yahoo Finance
Codexis to Participate in Upcoming Healthcare Conferences - GlobeNewswire
Codexis to Participate in Upcoming Healthcare Conferences - StockTitan
Codexis to Participate in Upcoming Healthcare Conferences - Yahoo Finance
Codexis Inc Stock (CDXS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):